🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir

    Takeda

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    phase 3 small molecule active

    1 trial

  2. masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib

    AB Science

    Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  3. masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib

    AB Science

    Amyotrophic Lateral Sclerosis

    phase 3 small molecule active

    1 trial

  4. mavrilimumab

    Kiniksa Pharmaceuticals International, plc

    COVID

    phase 3 small molecule completed

    1 trial

  5. metronomic adjuvant chemotherapy with capecitabine

    Chongqing Claruvis Pharmaceutical Co.,

    Nasopharyngeal Cancinoma (NPC)

    phase 3 small molecule active

    1 trial

  6. migalastat HCl 150 mg

    AMICUS THERAPEUTICS PTY LTD

    Fabry Disease

    phase 3 small molecule completed

    1 trial

  7. mipomersen

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  8. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  9. misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor Induction

    phase 3 small molecule completed

    1 trial

  10. mitoxantrone liposome, Ara-Cytarabine and azacitidine

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukaemia

    phase 3 small molecule active

    1 trial

  11. muraglitazar

    Bristol-Myers Squibb

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  12. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  13. nalbuphine HCl ER tablets 60 mg BID

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    1 trial

  14. nalbuphine HCl ER tablets 90 mg BID

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  15. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 mab completed

    1 trial

  16. normal saline solution for infusion, Ociperlimab, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Tislelizumab, Ociperlimab

    BeiGene

    Locally advanced, unresectable, or metastatic non small cell lung cancer

    phase 3 small molecule active

    1 trial

  17. nutritional supplement

    Abbott Australasia Pty Ltd

    Children

    phase 3 other completed

    1 trial

  18. obinutuzumab

    Hoffmann-La Roche

    Lymphocytic Leukemia, Chronic

    phase 3 small molecule completed

    1 trial

  19. ofloxacin

    ABEONA THERAPEUTICS INC.

    Diabetic Foot Ulcers

    phase 3 small molecule completed

    2 trials

  20. oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

    Takeda

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  21. pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer

    phase 3 mab completed

    2 trials

  22. pembrolizumab/vibostolimab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    phase 3 mab active

    1 trial

  23. pioglitazone

    Hoffmann-La Roche

    Diabetes Mellitus Type 2

    phase 3 small molecule completed

    1 trial

  24. placebo for risankizumab

    AbbVie

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources